Menu

AHA urged the Trump administration in a March 3 letter to halt Novo Nordisk’s plan to require all 340B covered entities to submit claims data for in-house pharmacy utilization as of April 1.

AHA Asks HRSA to Block Novo Nordisk, Lilly’s New 340B Claims Data Submission Policies

March 5, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

A national hospital trade group urged the Trump administration this week to halt pharmaceutical giant Novo Nordisk’s plan to require [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

340B Report Webinar Recap: Editorial Team Talks State Contract Pharmacy Laws and Court Actions, Federal Legislative Efforts

State Contract Pharmacy Lawsuit Roundup: Actions in West Virginia, Utah, Oklahoma and Colorado